InChI=1S/C46H78NO10P/c1-3-5-7-9-11-13-15-17-19-20-21-22-24-25-27-29-31-33-35-37-44(48)54-39-42(40-55-58(52,53)56-41-43(47)46(50)51)57-45(49)38-36-34-32-30-28-26-23-18-16-14-12-10-8-6-4-2/h5,7,11,13,17,19,21-22,25,27,31,33,42-43H,3-4,6,8-10,12,14-16,18,20,23-24,26,28-30,32,34-41,47H2,1-2H3,(H,50,51)(H,52,53)/b7-5-,13-11-,19-17-,22-21-,27-25-,33-31-/t42-,43+/m1/s1 |
YZPDRIODLGOXPQ-VQXQEPRVSA-N |
[H][C@](COP(OC[C@@](COC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)(OC(CCCCCCCCCCCCCCCCC)=O)[H])(=O)O)(C(O)=O)N |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via phosphatidyl-L-serine )
|
|
View more via ChEBI Ontology
(2S)-2-amino-3-({[(2R)-3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyloxy]-2-(octadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid
|
HMDB
|
1-Docosahexaenoyl-2-stearoyl-sn-glycero-3-phosphoserine
|
HMDB
|
Phosphatidylserine(22:6/18:0)
|
HMDB
|
Phosphatidylserine(22:6n3/18:0)
|
HMDB
|
Phosphatidylserine(22:6w3/18:0)
|
HMDB
|
Phosphatidylserine(40:6)
|
HMDB
|
PS(22:6/18:0)
|
HMDB
|
PS(22:6n3/18:0)
|
HMDB
|
PS(22:6w3/18:0)
|
HMDB
|
PS(40:6)
|
HMDB
|
PSer(22:6/18:0)
|
HMDB
|
PSer(22:6n3/18:0)
|
HMDB
|
PSer(22:6w3/18:0)
|
HMDB
|
PSer(40:6)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|